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January 2013292 AbstractsIncreased Risk For Adverse Events Following Re-Intervention In Pa-
tients With Restenosis After Prior CEA
Margriet Fokkema, MD,1 Gert Jan de Borst, MD PhD,2 Brian W. Nolan,
MD,3 Robert A. Cambria, MD,4 Richard J. Powell, MD,5 Andrew C.
Stanley, MD,6 Marc L. Schermerhorn, MD1. 1Beth Israel Deaconess Med-
ical Center, Boston, Mass; 2University Medical Center Utrecht, Utrecht,
Netherlands; 3Darthmouth-HitchcockMedical Center, Lebanon, NH; 4East-
ernMaineMedical Center, Bangor,Me; 5Dartmouth-HitchcockMedical Cen-
ter, Lebanon, NH; 6Fletcher Allen Health Care, Burlington, Vt
Objectives:Outcomes of patients undergoing reintervention for reste-
nosis after prior ipsilateral carotid endarterectomy (CEA) in the era of
carotid stenting (CAS) are unclear. We assessed perioperative results and
durability of CAS and CEA in symptomatic (SX) and asymptomatic (ASX)
patients undergoing reintervention.
Methods: Patients undergoing CAS and CEA were identified in the
Vascular Study Group of New England (VSGNE) between January 2003
and November 2011. Demographics, preoperative risk factors, 30-day out-
come (stroke/death), cranial nerve injury, and restenosis50% at follow-up
were compared across primary procedures and reinterventions (CAS vs
CEA). Fisher exact test or 2 test were used to analyze significance differ-
ences (P  .05) between the different groups.
Results: Of a total of 9357 CEA procedures (33% SX), 212 patients
(2.3%) underwent redoCEA (36% SX).Of 663CAS procedures (34% SX), 220
patients (33%) underwent CAS after prior ipsilateral CEA (31% SX). Demo-
graphics of patients undergoing CAS after prior CEA were comparable to
patients undergoing redo CEA. Forty percent of CAS patients had at least one
medical high-risk factor forCEA.Asymptomatic patients undergoing redoCEA
had a significantly higher stroke/death risk (3.0%) than primary CEA (0.9%),
but equivalent to CAS after prior CEA (2.0%; Table). No difference in periop-
erative cranial nerve injury was identified between redo CEA and primary CEA
(5.2% vs 4.7%). Follow-up was available for 56.7% of CAS (median, 254 days)
and 68% of CEA patients (median, 370 days). Redo CEA had higher rates of
50% restenosis than primary CEA (14.8% vs 9.8%, P  .06); there was no
significant difference between CAS after prior CEA (17.2%) compared with
redo CEA (14.8%, P .62) and primary CAS (18.6%, P .73).
Conclusions: In the VSGNE, CEA and CAS showed equivalent outcome
(30-day stroke/death risk and restenosis) in ASX and SX patients treated for
restenosis after prior ipsilateral CEA. However, regardless of procedure, the risk of
reintervention was increased compared with patients undergoing primary CEA.
Table. 30-day stroke/death risk for patients undergoing CEA or CAS
following prior ipsilateral CEA
ASX SX
Primary
Prior
CEA P-value Primary
Prior
CEA P value
CAS 0.7% 2.0% 0.35 7.6% 4.4% .56
CEA 0.9% 3.0% 0.04 1.8% 4.0% .16
P-value 1.0 0.71 .01 1.0
ASX, Asymptomatic, SX, symptomatic.
Bold values indicate, P value .05.
Office-Based Endovascular Suite Is Safe for Most Procedures
Krishna M. Jain, MD, John Munn, MD, Mark Rummel, Dan Johnston,
Chris Longton. Advanced Vascular Surgery, Kalamazoo, Mich
Objective: This study assessed the safety of endovascular procedures in
office setting over a long-term period.
Methods: Between May 22, 2005, and November 22, 2011, 2309
patients underwent 5029 percutaneous procedures in an office-based proce-
dural suite. Demographics of the patients, complications, and hospital transfers
were documented in a prospective manner. Follow-up calls were made, and a
satisfaction survey was administered. Most procedures were done under local
anesthesia or conscious sedation. All patients, except those having catheter
removal, received acetaminophen and hydrocodone (5/500), diazepam (5 to
10 mg), and one dose of an oral antibiotic preprocedure and three doses
postprocedure. Patients requiring conscious sedation received fentanyl and
midazolam. Conscious sedation was used in patients having peripheral arterial
interventions. Blood urea nitrogen, creatinine, international normalized ratio,
and partial thromboplastin time were performed prior to peripheral arterio-
grams. Patients on dialysis (end-stage renal disease) had no laboratory work
done preoperatively. Patients considered high risk, thosewho could not tolerate
the procedure with mild to moderate conscious sedation, or those who were
morbidly obese were not candidates for office-based procedures.
Results: There were no procedure-related deaths. Procedures and com-
plications are listed in the Table. There were 45 total complications (0.9%), of
which 20 (0.4%) were site related, 14 (0.3%) were deep venous thrombosis after
a venous procedure, and 11 (0.2%) were other medical problems. Seventeen
E
Srocedures required subsequent hospital transfer. Of those patients surveyed,
9% indicated that they would come back to the office for needed procedures.
Conclusions: When appropriately screened, almost all peripheral in-
erventions can be done in the office with minimal complications. For
ialysis patients, outpatient intervention has a very low complication rate and
s the mainstay of treatment to keep the dialysis access patent. Venous
nsufficiency when managed in the office setting also has a low complication
ate. Office-based procedural settings should be the preferred site for per-
utaneous interventions for arterial, venous, and dialysis-related procedures.
able. Office based procedural complications May 22, 2005–November 22, 2011
rocedure
Procedures
(No.)
Complications, No.
DVT
(No.)
Hospital
transfers
(No.)Total
Site-
related Medical
rteriogram with
runoff
422 6 5 1 2
rteriogram with
interventiona
325 7 6 1 5
istulogram 162 1 1 1
istulogram
interventionb
1375 2 1 1 1
istulogram with
thrombectomy
of dialysis
access
498 7 3 4 6
VLT 313 8 2 6
VLT & micro 427 9 2 7
icrophlebectomy 110 2 1 1
atheter insertion 329 2 2 1
atheter exchange 229
atheter gram 4
atheter removal 628
owerport 111
owerport removal 15
enogram 43
enoplasty 5
VC filter insertion 4 1 1 1
VC filter removal 29
Arteriogram interventions include angioplasty, coiling, stenting, atherectomy.
Fistulogram interventions include angioplasty, coiling, stenting.
obot-Assisted Vascular Surgery, 250 Cases
etr Stadler, Libor Dvoracek, MD, Petr Vitasek, MD, Pavel Matous, MD.
Na Homolce Hospital, Praha 5, Czech Republic
Objectives: The feasibility of laparoscopic aortic surgery has been ade-
uately demonstrated. Our clinical experience with robot-assisted aortoiliac
econstruction for occlusive diseases, aneurysms, endoleak II treatment and
ybrid procedures performed using the da Vinci system is described.
Methods: Between November 2005 and April 2012, we performed
50 robot-assisted vascular procedures. A total of 189 patients were pro-
pectively evaluated for occlusive diseases, 48 patients for abdominal aortic
neurysm, two for common iliac artery aneurysm, two for splenic artery
neurysm, one for internal mammary artery aneurysm, four for hybrid
rocedures, and four for endoleak II treatment after endovascular aneurysm
epair. The robotic system was applied to construct vascular anastomosis, for
hromboendarterectomy, for aortoiliac reconstruction with closure patch,
or dissection of the splenic artery, and for posterior peritoneal suture. A
ombination of conventional laparoscopic surgeries and robotic surgeries
ere routinely included. A modified, fully robotic approach without laparo-
copic surgery was used in the last 80 cases in our series.
Results: A total of 241 cases (96,4%) were successfully completed
obotically, one patient’s surgery was discontinued during laparoscopy due
o heavy aortic calcification. Conversion was necessary in eight patients
3.2%). The 30-day mortality rate was 0.4%, and nonlethal postoperative
omplications were observed in 13 patients (5.2%).
Conclusions: Our experience with robot-assisted laparoscopic surgery has
emonstrated the feasibility of this technique for occlusive diseases, aneurysms,
ndoleak II treatment after endovascular aneurysm repair, and hybrid procedures.
he da Vinci robotic system facilitated the creation of the aortic anastomosis and
hortened the aortic clamping time comparedwith purely laparoscopic techniques.
dentifying TAAA IV Patients at High Risk for Open Repair
apan S. Desai, MD, PhD,MBA, Kristofer Charlton-Ouw, MD, Harleen K.
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chool and Memorial Hermann Hospital, Houston, Tex
